Surgical management of breast cancer: today and tomorrow

Cancer Biotherapy & Radiopharmaceuticals
Richard J Bold

Abstract

The surgeon continues to play a key role in the initial local/regional management of breast cancer. Breast conserving therapy (BCT) utilizing segmental mastectomy has been developed as an alternative to total mastectomy to improve cosmetic and psychosocial outcomes while retaining oncologic benefits. Developments in the surgical treatment of breast cancer have changed the way breast cancer is diagnosed and treated, and will likely continue to evolve in the future. This review highlights aspects of breast cancer treatment in which the surgical approach has evolved or is evolving, and comments on how the surgeon may participate in breast cancer care in the future.

References

Nov 30, 1995·The New England Journal of Medicine·M C ChristianM A Friedman
May 6, 1995·Lancet·M J SilversteinD J Slamon
Jan 1, 1994·Radiology·K K Lindfors, C J Rosenquist
Jun 1, 1996·Cancer·M J SilversteinD N Poller
Jul 1, 1996·Plastic and Reconstructive Surgery·S S KrollM A Schusterman
Oct 1, 1996·AJR. American Journal of Roentgenology·R J Brenner, J M Pfaff
Jul 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherN V Dimitrov
Dec 16, 1997·The Australian and New Zealand Journal of Surgery·L Irwig, A Bennetts
Feb 7, 1998·Spine·G B AnderssonJ N Weinstein
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherM Kavanah
Dec 30, 1998·Annals of Surgical Oncology·E B FishH L Lickley
Feb 16, 2000·Annals of Surgical Oncology·S PendasD S Reintgen
Feb 19, 2000·Hematology/oncology Clinics of North America·G G Kimmick, L Balducci
Mar 11, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B Fisher
Mar 29, 2000·CA: a Cancer Journal for Clinicians·R T GreenleeP A Wingo
Apr 22, 2000·Cancer Treatment Reviews·G H Sakorafas, A G Tsiotou
Aug 15, 2000·Cancer Biotherapy & Radiopharmaceuticals·S S JeffreyK L Smith
Aug 16, 2000·Radiologic Clinics of North America·L Liberman
Sep 7, 2000·Journal of the National Cancer Institute·J H RowlandP A Ganz
Nov 9, 2000·Seminars in Ultrasound, CT, and MR·J A HarveyG A DeAngelis
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·P I HaighA E Giuliano
Feb 15, 2001·Plastic and Reconstructive Surgery·W N AndradeJ L Semple
Apr 21, 2001·Annals of Surgical Oncology·P ShenA E Giuliano
May 12, 2001·The Breast Journal·D. David Dershaw
May 12, 2001·The Breast Journal·Douglas ReintgenCharles E. Cox
May 12, 2001·The Breast Journal·Patricia A. Ganz
May 15, 2001·Endocrine-related Cancer·K A Skinner, M J Silverstein
Aug 29, 2001·Annals of Surgery·K M McMastersUNKNOWN University of Louisville Breast Cancer Study Group
Jan 5, 2002·Cancer Biotherapy & Radiopharmaceuticals·R J BoldB N Fahy
Mar 20, 2002·Clinical Breast Cancer·P R Kelemen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.